首页> 外文期刊>Environmental toxicology and chemistry >Environmental Risk Assessment for the Active Pharmaceutical Ingredient Mycophenolic Acid in European Surface Waters
【24h】

Environmental Risk Assessment for the Active Pharmaceutical Ingredient Mycophenolic Acid in European Surface Waters

机译:欧洲地表水中活性药物成分麦考酚酸的环境风险评估

获取原文
获取原文并翻译 | 示例
       

摘要

An environmental risk assessment is presented for mycophenolic acid (MPA), an immunosuppressive pharmaceutical used for prevention of organ rejection, and its prodrug mycophenolate mofetil (MPM). Mycophenolic acid will not significantly adsorb to activated sludge. In activated sludge, C-14-MPA attained >80% degradation, supporting an older environmental fate test with the same compound. Based on n-octanol/water distribution coefficient (log D-OW) values of 2.28, 0.48, and <=-1.54 at pH 5, 7, and 9, respectively, MPA is not expected to bioaccumulate. Sales amounts of MPA+MPM in Europe were used to derive predicted environmental concentrations (PECs) in surface waters; PECs were refined by including expected biodegradation in sewage treatment, average drinking water use, and average dilution of the effluents in the receiving waters per country. In addition, the exposure to pharmaceuticals in the environment (ePiE) model was run for 4 European catchments. The PECs were complemented with 110 measured environmental concentrations (MECs), ranging from below the limit of quantitation (<0.001 mu g/L) to 0.656 mu g/L. Predicted no-effect concentrations (PNECs) were derived from chronic tests with cyanobacteria, green algae, daphnids, and fish. The comparison of PECs and MECs with the PNECs resulted in a differentiated environmental risk assessment in which the risk ratio of PEC/PNEC or MEC/PNEC was <1 in most cases (mostly >90%), meaning no significant risk, but a potential risk to aquatic organisms in generally <10% of instances. Because this assessment reveals a partial risk, the following questions must be asked: How much risk is acceptable? and Through which measures can this risk be reduced? These questions are all the more important in view of limited alternatives for MPM and MPA and the serious consequences of not using them. Environ Toxicol Chem 2019;38:2259-2278. (c) 2019 The Authors. Environmental Toxicology and Chemistry published by Wiley Periodicals, Inc. on behalf of SETAC.
机译:针对霉酚酸(MPA)(一种用于预防器官排斥的免疫抑制药物)及其前药霉酚酸酯(MPM),提出了环境风险评估。霉酚酸不会明显吸附到活性污泥上。在活性污泥中,C-14-MPA的降解率> 80%,支持使用相同化合物进行的较早的环境归宿测试。基于分别在pH 5、7和9下的2.28、0.48和<=-1.54的正辛醇/水分配系数(log D-OW)值,预计MPA不会生物累积。在欧洲,MPA + MPM的销售量用于得出地表水中的预测环境浓度(PEC);通过包括预期的污水处理中的生物降解,平均饮用水使用量以及每个国家/地区接收水的废水的平均稀释度来完善PEC。此外,还针对4个欧洲流域进行了环境药物(ePiE)模型的暴露。 PEC补充了110种测量的环境浓度(MEC),范围从低于定量限(<0.001μg / L)到0.656μg / L。预测的无效应浓度(PNECs)来自对蓝细菌,绿藻,蚤类和鱼类的长期测试。 PECs和MECs与PNECs的比较导致了差异化的环境风险评估,在大多数情况下,PEC / PNEC或MEC / PNEC的风险比<1(大多数> 90%),这意味着没有重大风险,但存在潜在风险一般情况下,对水生生物的风险小于10%。由于此评估表明存在部分风险,因此必须提出以下问题:可接受多少风险?通过哪些措施可以减少这种风险?鉴于MPM和MPA的替代方案有限以及不使用它们的严重后果,这些问题变得更加重要。 Environ Toxicol Chem 2019; 38:2259-2278。 (c)2019作者。 Wiley Periodicals,Inc.代表SETAC发布的《环境毒理学和化学》。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号